title: Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer.
abstract: Insulin resistance is a well-documented risk factor for the development of endometrial cancer. Adiponectin and vaspin are insulin-sensitizing proteins that are secreted from adipose tissue. A clear association between serum levels of adipokines and endometrial cancer has yet to be established. The study group consisted of postmenopausal women with confirmed endometrial cancer, whereas patients with benign endometrial conditions constituted the control group. The two groups were compared in terms of insulin resistance and serum levels of adiponectin and vaspin. A total of 60 patients with confirmed endometrial cancer and 70 controls with benign endometrial conditions (polyps and atrophy) were enrolled. Median homeostasis model assessment of insulin resistance value was significantly higher in the study group compared with the control group (2.93 vs 1.27, P<0.0001), whereas mean quantitative insulin sensitivity check index value was significantly lower (0.33 ± 0.02 vs 0.37 ± 0.37, P<0.0001). Median values for both adiponectin and vaspin were significantly lower in patients with endometrial cancer compared with the control group (4.09 vs 17.13 μg/ml, P<0.0001 and 0.21 vs 0.39 ng/ml, P<0.0001 respectively). Low levels of both adiponectin and vaspin were found to be significantly associated with an increased risk for endometrial cancer. Following adjustment for confounding factors, the respective odds ratios for endometrial cancer in patients in the first tertile compared with those in the third tertile were 10.80 (2.76-42.24; P=0.001) and 13.23 (2.94-59.64; P=0.001). Our results show that lower levels of circulating adiponectin and vaspin levels are associated with an increased risk of developing endometrial cancer.
authors.affiliation: Department of Clinical Biochemistry, Numune Training and Research Hospital, Ankara, Turkey. drsturhan@yahoo.com
authors.forename: Serpil
authors.initials: S
authors.lastname: Erdogan
authors.forename: Sevilay
authors.initials: S
authors.lastname: Sezer
authors.forename: Eralp
authors.initials: E
authors.lastname: Baser
authors.forename: Ozlem
authors.initials: O
authors.lastname: Gun-Eryilmaz
authors.forename: Tayfun
authors.initials: T
authors.lastname: Gungor
authors.forename: Sema
authors.initials: S
authors.lastname: Uysal
authors.forename: Fatma Meric
authors.initials: FM
authors.lastname: Yilmaz
mesh_terms: D000230:Adenocarcinoma / Q000097:blood* / Q000453:epidemiology; D052242:Adiponectin / Q000097:blood*; D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D016889:Endometrial Neoplasms / Q000097:blood* / Q000453:epidemiology; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008875:Middle Aged; D016017:Odds Ratio; D017698:Postmenopause; D011446:Prospective Studies; D015843:Serpins / Q000097:blood*
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin; C507339:SERPINA12 protein, human; D015843:Serpins
keywords: adiponectin; endometrial cancer; insulin resistance; vaspin